| Volume 18, 2014 Articles |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
PreScription: The International Journal of Pharmaceutical Compounding Begins Its 18th Year
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 4
|
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013
Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
|
Jan/Feb 2014
Pg. 6-12
|
Using Compounded Medications for the Topical Treatment of Complex Regional Pain Syndrome Type I Following Trauma: A Case Report
Zur Eyal
|
Jan/Feb 2014
Pg. 14-19
|
Good Enough for America
Worthen Dennis B
|
Jan/Feb 2014
Pg. 20-29
|
Determination of Risk for Sterile Preparations
Freedman ben-Horin Shimon, Rousso Tamaro
|
Jan/Feb 2014
Pg. 30-34
|
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013
Miller David G
|
Jan/Feb 2014
Pg. 35-36
|
Marketing
Moore Renee
|
Jan/Feb 2014
Pg. 38
|
Tips and Hints: Powders, Capsules, Tablets, Suppositories, and Sticks
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 42-45
|
Quality Control Analytical Methods: Laboratory Considerations of United States Pharmacopeia Chapter <71> Sterile Tests and Its Application to Pharmaceutical Compounding
Hyde Tiffany D
|
Jan/Feb 2014
Pg. 46-52
|
Basics of Sterile Compounding: Bubble Point Testing
Thoma Laura
|
Jan/Feb 2014
Pg. 54-57
|
Calculations
Stockton Shelly J
|
Jan/Feb 2014
Pg. 58-59
|
Aztreonam Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 60
|
Bumetanide 0.25-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 61
|
Droperidol 2.5-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 62
|
Lomustine 100-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 63
|
Neostigmine Bromide 15-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 64
|
Nimodipine 30-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 65
|
Phenobarbital 60-mg Capsules
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 66
|
Potassium Chloride 2-mEq/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 67
|
Procainamide Hydrochloride 100-mg/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 68
|
Vasopressin 20-units/mL Injection
Allen Loyd V Jr
|
Jan/Feb 2014
Pg. 69
|
The Effectiveness of Sublingual and Topical Compounded Bioidentical Hormone Replacement Therapy in Post-menopausal Women: An Observational Cohort Study
Ruiz Andres D, Daniels Kelly R
|
Jan/Feb 2014
Pg. 70-77
|
Long-term Stability of Morphine Hydrochloride in 0.9% NaCl Infusion Polyolefin Bags After Freeze-thaw Treatment and in Polypropylene Syringes at 5°C ± 3°C
Hecq J-D, Godet M, Gillet P, Jamart J, Galanti L
|
Jan/Feb 2014
Pg. 78-82
|
E-Prescribing Errors Identified in a Compounding Pharmacy: A Quality-improvement Project
Reed-Kane Dana, Kittell Katrina, Adkins Jacquelyn, Flocks Sarah, Nguyen Thu
|
Jan/Feb 2014
Pg. 83-86
|
PostScription: Pharmacy Benefit Managers and Compounding Pharmacists: Billing for Services
Lees Deril J
|
Jan/Feb 2014
Pg. 87
|
PreScription: Standards vs Opinions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 92
|
A Needle-free Reconstitution and Transfer System for Compounded Sterile Intravenous Drug Solutions: In Compliance with United States Pharmacopeia Chapter <797> Standards
Marks Zach
|
Mar/Apr 2014
Pg. 94-99
|
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective
Timko Robert J, Crooker Philip EM
|
Mar/Apr 2014
Pg. 101-111
|
Compounding Practices in Iran
Goodarzi Navid, Niknam Somayeh, Akbarzadeh Tahmineh, Gholami Kheirollah
|
Mar/Apr 2014
Pg. 112-116
|
IACP's Continuing Support of Compounding Pharmacists: Letter to the FDA Concerning 503B Outsourcing Facilities
Miller David G
|
Mar/Apr 2014
Pg. 117-118
|
Effective Advertisements
Moore Renee
|
Mar/Apr 2014
Pg. 120-121
|
Quality Control Analytical Methods: The Essentials of United States Pharmacopeia Chapter <51> Antimicrobial Effectiveness Testing and Its Application in Pharmaceutical Compounding
Vu Nicole, Nguyen Devin, Kupiec Thomas C
|
Mar/Apr 2014
Pg. 123-130
|
Basics of Sterile Compounding: Compounding by Weight Versus Compounding by Volume
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 131-134
|
Basics of Compounding: Tips and Hints, Part 2: Compounding with Solutions, Suspensions, Emulsions, and Lotions
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 137-138
|
Calculations
Stockton Shelly J
|
Mar/Apr 2014
Pg. 140-141
|
Doxazosin 1-mg, 2-mg, 4-mg, or 8-mg Capsules
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 142
|
Fludarabine Phosphate 25-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 143
|
Mecasermin 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 144
|
Methylprednisolone 40-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 145
|
Polymixin B Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 146
|
Rocuronium Bromide 10-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 147
|
Secretin 4 mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 148
|
Selenium 40-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 149
|
Sincalide 1-mcg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 150
|
Testosterone Enanthate 200-mg/mL Injection
Allen Loyd V Jr
|
Mar/Apr 2014
Pg. 151
|
Chemical and Physical Compatibility of an Intravenous Solution of Epinephrine with Calcium Chloride
Weeks Phillip A, Teng Yang, Wu Lei, Sun Mary, Yang Zhen, Chow Diana S-L
|
Mar/Apr 2014
Pg. 152-158
|
E-Prescription Errors and Their Resolution in a Community Compounding Pharmacy
Reed-Kane Dana, Vasquez Kellie, Pavlik Aaron, Pergine Johanna, Sandberg Michelle
|
Mar/Apr 2014
Pg. 159-161
|
The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding
Wiley TS, Odegard RD, Raden J, Haraldsen JT
|
Mar/Apr 2014
Pg. 162-168
|
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
|
Mar/Apr 2014
Pg. 169-174
|
Recharting Your Vision While Remaining True to Your Charter
Hesterlee Edward J
|
Mar/Apr 2014
Pg. 175
|
PreScription: Déjà Vu All Over Again
Allen Loyd V Jr
|
May/Jun 2014
Pg. 180
|
A Brief Survey on Prescriber Beliefs Regarding Compounded Topical Pain Medications
Warner Meredith, Tuder Dmitry
|
May/Jun 2014
Pg. 182-188
|
Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice
McNulty John P, Muller George
|
May/Jun 2014
Pg. 190-200
|
Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation
Phan Ha, DeReese Annie, Day A J, Carvalho Maria
|
May/Jun 2014
Pg. 203-207
|
The U.S. Food and Drug Administration Responds to the International Academy of Compounding Pharmacists' Outsourcing Letter
Miller David G
|
May/Jun 2014
Pg. 208
|
Marketing: Effective Use of Advertisements on Your Website
Moore Renee
|
May/Jun 2014
Pg. 210-211
|
Quality Control Analytical Methods: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 1
Vu Nicole, Lou Jessica R, Kupiec Thomas
|
May/Jun 2014
Pg. 213-221
|
Quality Control Analytical Methods: Establishing Powder-handling Workflow Practices and Standard Operating Procedures: Compounding Pharmacy and Safety
Prince Bryan, Lundevall Jeremy
|
May/Jun 2014
Pg. 222-226
|
Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams
Allen Loyd V Jr
|
May/Jun 2014
Pg. 228-230
|
Calculations
Stockton Shelly J, Saluja Hardeep Singh
|
May/Jun 2014
Pg. 231
|
Atorvastatin 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 232
|
Bumetanide 0.5-mg, 1-mg, or 2-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 233
|
Bupivacaine Hydrochloride 0.5% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 234
|
Butorphanol Tartrate 10-mg/mL Nasal Spray
Allen Loyd V Jr
|
May/Jun 2014
Pg. 235
|
Dibucaine 1% Ointment
Allen Loyd V Jr
|
May/Jun 2014
Pg. 236
|
Lidocaine Hydrochloride 1% Injection
Allen Loyd V Jr
|
May/Jun 2014
Pg. 237
|
Methotrexate 2.5-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 238
|
Naproxen 25-mg/mL Oral Suspension
Allen Loyd V Jr
|
May/Jun 2014
Pg. 239
|
Tamoxifen 10-mg or 20-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 240
|
Thiothixene 1-mg, 2-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
May/Jun 2014
Pg. 241
|
Examination of the Order of Incubation for the Recovery of Bacteria and Fungi from Pharmaceutical-grade Cleanrooms
Sandle Tim
|
May/Jun 2014
Pg. 242-247
|
Investigation of Physical and Chemical Stability of an Ointment with Herbals
Zdoryk Oleksandr A, Khokhlova Kateryna O, Georgiyants Victoriya A, Vyshnevska Liliia I
|
May/Jun 2014
Pg. 248-252
|
Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
May/Jun 2014
Pg. 253-255
|
Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery
Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
|
May/Jun 2014
Pg. 256-261
|
PostScription: The Fourth Annual Student Pharmacist Compounding Competition: Building Future Leaders in the Industry
Bastos Dea
|
May/Jun 2014
Pg. 262-263
|
PreScription: Challenging Times
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 268
|
Vial Washers for the Compounding Pharmacy: Ensuring Preparation Safety
Johnson Kain, Sully Andrew, Anthenat Bruce
|
Jul/Aug 2014
Pg. 270-276
|
Compounded Pain Formulations: What is the Evidence?
Asbill Scott, Sweitzer Sarah M, Spigener Shuler, Romero-Sandoval Alfonso
|
Jul/Aug 2014
Pg. 278-286
|
Oral Mucosal Immunotherapy Using a Toothpaste Delivery System for the Treatment of Allergic Rhinitis
Reisacher William, Rudner Shara, Kotik Viktoriya
|
Jul/Aug 2014
Pg. 287-290
|
Color Additives: Legislative Perspective in the United States, Europe, Australia, and India
Kumar Anuj, Madan Anil K
|
Jul/Aug 2014
Pg. 293-300
|
400 Attendees Convene in Washington, D.C., for the 20th Annual Compounders on Capitol Hill
Miller David G
|
Jul/Aug 2014
Pg. 302
|
Quality Control: Microbial Limit Tests for Nonsterile Pharmaceuticals, Part 2
Vu Nicole, Lou Jessica R, Kupiec Thomas C
|
Jul/Aug 2014
Pg. 305-310
|
Basics of Compounding Sterile Preparations: Nomenclature and Considerations
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 313-317
|
Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 318-319
|
Calculations
Stockton Shelly J
|
Jul/Aug 2014
Pg. 320-321
|
Atracurium Besylate 10-mg/mL Injection, Preserved
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 322
|
Barium Sulfate Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 323
|
Calcitriol 1-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 324
|
Chloramphenicol 100-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 325
|
Chlorothiazide 50-mg/mL Oral Suspension
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 326
|
Choline Magnesium Trisalicylate Liquid
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 327
|
Denileukin Diftitox 150-mcg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 328
|
Indigo Carmine Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 329
|
Propranolol Hydrochloride 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 330
|
Zinc 1-mg/mL Injection
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 331
|
Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream
Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
|
Jul/Aug 2014
Pg. 332-340
|
Assessing the Use of Food Coloring as an Appropriate Visual Guide for Homogenously Mixed Capsule Powders in Extemporaneous Compounding
Hoffmann Brittany, Carlson Christie, Rao Deepa A
|
Jul/Aug 2014
Pg. 341-344
|
Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita
|
Jul/Aug 2014
Pg. 345-347
|
Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date
Peacock Gina F, Sauvageot Jurgita, Addo Richard T
|
Jul/Aug 2014
Pg. 348-350
|
PostScription: Responsibilities of a Compounding Pharmacist
Allen Loyd V Jr
|
Jul/Aug 2014
Pg. 351
|
PreScription: What is a Compounding Pharmacist?
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 356
|
Roboticized Compounding of Oncology Drugs in a Hospital Pharmacy
Palma Elisabetta, Bufarini Celestino
|
Sep/Oct 2014
Pg. 358-364
|
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Eichstadt Lauren R, Davidson Gigi S
|
Sep/Oct 2014
Pg. 366-369
|
Autologous Serum Eye Drops for Severe Dry Eye Syndrome in a Patient with Chronic Graft-vs-Host Disease: A Case Report
Mixon Bill, Mixon Jan, Isbey Edward K III, Sprinkle Shari
|
Sep/Oct 2014
Pg. 370-377
|
Final Guidance for Pharmacy Compounding of Human Drug Products Under Section 503A
Blankenship Cynthia E
|
Sep/Oct 2014
Pg. 379-380
|
Health Care in Belarus in the 19th and 20th Centuries
Tishchenko Evgenii Mikhailovich
|
Sep/Oct 2014
Pg. 382-391
|
Compounding Practices in a Portuguese Community Pharmacy
Reis Maria, Carvalho Maria, Rodrigues Angelo
|
Sep/Oct 2014
Pg. 392-395
|
Basics of Compounding: Certification of Sterile Equipment and Facilities: What Pharmacists Need to Know
Lanze Amanda, Rudner Shara
|
Sep/Oct 2014
Pg. 397-399
|
Basics of Compounding: Tips and Hints, Part 5: Facilities and Equipment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 401-404
|
Marketing: Tips on Dealing With a Healthcare Practititioner's No-Rep Policy
Moore Renee
|
Sep/Oct 2014
Pg. 406
|
Calculations
Stockton Shelly J
|
Sep/Oct 2014
Pg. 407
|
Azithromycin 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 408
|
Bacitracin Topical Ointment
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 409
|
Dexpanthenol 250-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 410
|
Ephedrine Sulfate 50-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 411
|
Fluorescein 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 412
|
Indocyanine green 2.5-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 413
|
Phenylephrine Hydrochloride 2.5%-Ophthalmic Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 414
|
Sulfamethoxazole and Trimethoprim Oral Solution
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 415
|
Sumatriptan Succinate 12-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 416
|
Tranexamic Acid 100-mg/mL Injection
Allen Loyd V Jr
|
Sep/Oct 2014
Pg. 417
|
Stability and In Vitro Toxicity of an Infliximab Eye Drop Formulation
Robert Marie-Claude, Spurr-Michaud Sandra, Frenette Mathieu, Young David, Gipson Ilene K, Dohlman Claes H
|
Sep/Oct 2014
Pg. 418-426
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
Stability of Tranexamic Acid in 0.9% Sodium Chloride, Stored in Type 1 Glass Vials and Ethylene/Propylene Copolymer Plastic Containers
McCluskey Susan V, Sztajnkrycer Matthew D, Jenkins Donald A, Zietlow Scott P, Berns Kathleen S, Park Myung S
|
Sep/Oct 2014
Pg. 432-437
|
PostScription: The Future of Veterinary Compounding
Jordan Dinah G
|
Sep/Oct 2014
Pg. 438-439
|
PreScription: "Named Formulas" Database Available
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 444
|
Depyrogenation Options for the Compounding Cleanroom
Weller Tom, Bell Jeff, Dullinger Roger, Allen Vern, Anthenat Bruce
|
Nov/Dec 2014
Pg. 446-454
|
Standards of Practice, Professional Judgment, and Scientific Evidence to Establish and Extend a Beyond-Use Date
Thomson Cassandra Marie, Savji Taslim
|
Nov/Dec 2014
Pg. 456-460
|
Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Medications in a Rural Setting: A Case Study from the Delmarva Peninsula
Sherr Zachary, Karara Adel H
|
Nov/Dec 2014
Pg. 462-468
|
Compounding Legislation: Focus Shifts to States
Miller David G
|
Nov/Dec 2014
Pg. 470-472
|
Quality Control: Can Compounding Pharmacy Learn from the Automotive Industry?
Dillon L Rad
|
Nov/Dec 2014
Pg. 475-477
|
Basics of Compounding: Unique and Special Characteristics of Sterile Dosage Forms
Akers Michael J
|
Nov/Dec 2014
Pg. 479-484
|
Basics of Compounding: Tips and Hints, Part 6: Prescription Evaluation, Calculations, Ingredients, Quality-Assurance Practices, Patient Counseling, Shipping and Distribution, Miscellaneous
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 486-488
|
Marketing: Using Facebook to Market Your Compounding Pharmacy
Moore Renee
|
Nov/Dec 2014
Pg. 490-491
|
Calculations
Stockton Shelly J
|
Nov/Dec 2014
Pg. 492-493
|
Clarithromycin 250-mg or 500-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 494
|
Dexmedetomidine 100 mcg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 495
|
Dexmethylphenidate Hydrochloride 2.5-mg, 5-mg, or 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 496
|
Leucovorin 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 497
|
Levocarnitine 200-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 498
|
Methazolamide 25-mg or 50-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 499
|
Methylene Blue 10-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 500
|
Methylphenidate Hydrochloride 10-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 501
|
Oxacillin Sodium 167-mg/mL Injection
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 502
|
Tamsulosin Hydrochloride 0.2-mg Capsules
Allen Loyd V Jr
|
Nov/Dec 2014
Pg. 503
|
Skin Penetration and Antinociception of Topical Gabapentin Formulations
Bryson Evan, Asbill Scott, Sweitzer Sarah
|
Nov/Dec 2014
Pg. 504-511
|
In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations
Heustess Allie, Asbill Scott, Eagerton David, Arnold John
|
Nov/Dec 2014
Pg. 512-515
|
Effect of Emulsifier Pairs on Physical Stability of Emulsions Containing Three Different Natural Oils
Boonme Prapaporn, Maneenuan Duangkhae
|
Nov/Dec 2014
Pg. 516-519
|
High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products
Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
|
Nov/Dec 2014
Pg. 520-525
|
PostScription: Pharmacy Compounding Accreditation Board: Past, Present, and Future
Cabaleiro Joe
|
Nov/Dec 2014
Pg. 526-527
|
